We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$809M
AUM Growth
+$404M
Cap. Flow
+$13B
Cap. Flow %
1,601.81%
Top 10 Hldgs %
38.43%
Holding
159
New
60
Increased
32
Reduced
34
Closed
31

Top Buys

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$12.6B
2
AGN
Allergan plc
AGN
+$27.3M
3
ABBV icon
AbbVie
ABBV
+$22.4M
4
SHPG
Shire pic
SHPG
+$19.6M
5
PFE icon
Pfizer
PFE
+$18.3M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$12.7M
2
GSK icon
GSK
GSK
+$9.95M
3
BIIB icon
Biogen
BIIB
+$6.94M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$5.6M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 57.07%
2 Technology 4.45%
3 Energy 3.1%
4 Industrials 2.68%
5 Materials 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCRX
101
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1.57M 0.19%
321,254
+194,206
+153% +$1.12M
RCPT
102
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.55M 0.19%
25,000
-35,000
-58% -$1.67M
EPZM
103
DELISTED
Epizyme, Inc
EPZM
$1.36M 0.17%
50,000
-63,188
-56% -$1.96M
CYTK icon
104
Cytokinetics
CYTK
$10.5B
$1.28M 0.16%
363,212
+298,112
+458% +$1.25M
GNVC
105
DELISTED
GenVec, Inc.
GNVC
$1.16M 0.14%
55,833
-1,667
-3% -$36.6K
CYTO
106
DELISTED
Altamira Therapeutics Ltd
CYTO
$1.11M 0.14%
+2
New +$991K
ENLV icon
107
Enlivex Ltd
ENLV
$35.2M
$1.09M 0.13%
+250
New +$1.22M
PTN
108
Palatin Technologies
PTN
$13.7M
$1.01M 0.12%
+868
New +$1.05M
AFMD
109
DELISTED
Affimed
AFMD
$945K 0.12%
+15,000
New +$936K
WINT
110
DELISTED
Windtree Therapeutics Inc
WINT
$893K 0.11%
34,679
-1,035
-3% -$25K
ARCT icon
111
CALL
Arcturus Therapeutics
ARCT
$164M
$866K 0.11%
+8,014
New +$1.04M
CASC
112
DELISTED
Cascadian Therapeutics, Inc.
CASC
$822K 0.1%
71,333
-51,723
-42% -$790K
ZSPH
113
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$811K 0.1%
+20,682
New +$684K
TLOG
114
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$808K 0.1%
194,200
-5,800
-3% -$27K
PRTA icon
115
Prothena Corp
PRTA
$425M
$663K 0.08%
+29,907
New +$634K
MBOT icon
116
Microbot Medical
MBOT
$116M
$612K 0.08%
300
-9
-3% -$23.7K
KBIO
117
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$542K 0.07%
43,695
-1,305
-3% -$18K
ORA icon
118
Ormat Technologies
ORA
$6B
$522K 0.06%
19,889
-3,583
-15% -$97.5K
BLRX
119
BioLineRX
BLRX
$12.3M
$298K 0.04%
322
-678
-68% -$728K
CNCE
120
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$286K 0.04%
+22,700
New +$220K
BCLI
121
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$265K 0.03%
+4,222
New +$260K
SMMF
122
DELISTED
Summit Financial Group, Inc.
SMMF
$63K 0.01%
25,000
+24,223
+3,118% +$251K
MCUR
123
DELISTED
Macrocure Ltd.
MCUR
$51K 0.01%
+7,100
New +$59.8K
TTPH
124
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$47K 0.01%
118
-9,782
-99% -$2.62M
AUXL
125
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$30K ﹤0.01%
+1,000
New +$21.2K
3 4
5
6 7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sphera Funds Management held 159 positions worth $809M, up 99% from $406M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sphera Funds Management deployed $13B of net new capital in Q3 2014, opening 60 new positions and adding to 32 existing holdings. Its largest new stake was Isramco Inc: 103,111,944 shares worth $22.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 74% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was GSK, an estimated $9.95M trimmed.

  • Sphera Funds Management's largest Q3 2014 buy was Isramco Inc: 103,111,944 shares worth $22.1M.
  • Sphera Funds Management added most to Shire pic in Q3 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q3 2014 reduction was GSK, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Sanofi in Q3 2014, selling an estimated $12.7M.
  • Sphera Funds Management's ten largest holdings make up 38% of its $809M portfolio in Q3 2014.
  • Sphera Funds Management opened 60 new positions and closed 31 in Q3 2014.
  • Sphera Funds Management's portfolio value rose 99% quarter-over-quarter to $809M.

Based on Sphera Funds Management's 13F filing for Q3 2014, filed 13 Nov 2014.